The randomized trials of vitamins D in heart disease have been mostly disappointing, despite promising mechanistic studies in animal models and promising epidemiology.
Link to the full review article:
Paper · Nutr Metab (Lond) · 2026The vitamin D-cardiovascular nexus unraveling mechanistic promise and trial realityBackground Epidemiological data consistently associate low vitamin D status with elevated cardiovascular risk, yet causal mechanisms remain contested. Methods This review synthesized evidence through a protocol-guided approach, with database searches (PubMed/Embase/Web of Science; 2010–2024) focused on RCTs, mechanistic studies of cardiovascular pathways, and high-quality meta-analyses (AMSTAR-2 score ≥ 8). Results…link.springer.comAside from bone health, the strongest evidence for vitamin D from human RCT’s is in preventing and slowing autoimmune diseases:
↪ VITAL: vitamin D 2000 IU for over 2 years cut autoimmune disease risk about 40%
↪ JAMA RCT: high-dose vitamin D reduced disease activity in early multiple sclerosis
#vitamindHD #cvdHD #vitamindparadoxHD
————-

